Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-17 13:20:32 EDT

PhotosVideosAllPeople
LatestRanked
@byrdnick.comSep 7, 2026, 4:04 PM

One reason #antibiotics are overused is "diagnostic uncertainty".

An #rapidTesting can quickly increase certainty.

So @isilcoklar.bsky.social et al. have been talking to clinicians and patients to find ways to increase use of point-of-care, C-Reactive Protein #diagnostics

More: lnkd.in/p/e5uV4Yg5

Intervention Development Pathway(s)Barriers & Facilitators to CRP POCT Use

10 Theoretical Domains Framework (TDF) domains were identified from GP interviews, spanning all three COM-B components - Capability, Opportunity, Motivation.

Barriers
• Diagnostic uncertainty about CRP POCT validity
• Workload and time pressure in consultations
• Cost, calibration and space for the test
• Risk aversion and fear of litigation
• Patient pressure and low health literacy

Facilitators
• Greater diagnostic confidence and safety
• Structured tools: red-flag prompts, scoring
• Real-time CRP availability supports decisions
• Belief prudent prescribing benefits patients
• Peer-delivered education and prescribing feedbackPatient/Carer Perspectives (WP3)

Triangulation of results/How Patient/Carer Interview Findings Link to the Intervention Design


Component 1 - Blended Learning: A test result makes it easier for patients to accept a non-prescribing decision; has been described as "peace of mind"

Component 2 - Implementation & Audit: Pharmacy testing preferred for access and cost; views on who should deliver testing (GPs/ CPs/nurses) shape the delivery model and referral pathway

Component 3 - Patient Resources: Wide variation in AMR awareness; AMR rarely discussed in consultations; patients want accessible, plain-language materials

Cross-cutting - implementation & equity: State funding seen as essential; individual cost models risk excluding patients who can't afford to payTask Group Meeting: Finalising the Intervention

• Expert panel review - all three intervention components retained

• GP training: a short online module followed by a face-to-face CPD workshop with role-play, run as a CPD/CME-accredited* session at an existing ICP (Irish College of General Practitioners) conference if possible (not for the feasibility study)

• Workflow tools: the CRP device and consultation prompts add only 1-2 minutes per consultation; monthly feedback can be built as a Ql audit that counts toward GPs' mandatory professional development requirements

• Patient materials: plain-language resources building on existing HSE materials - the best-received component, seen as low-burden and supportive rather than adding to the consultation

* CPD=Continuous Professional Development, CME=Continuing Medical Education
@cardiophoenix.bsky.socialSep 7, 2026, 12:46 PM

The Class II recall of endotoxin-variable sponges highlights why tight supplier control and lot endotoxin testing are non-negotiable in a medical-device QMS.

#ECG #PrimaryCare #Diagnostics

@drsarahwh.bsky.socialSep 7, 2026, 8:12 AM

PMA nod for BAGUERA®C (Class III) is welcome, it demands real QMS: design controls, CAPA, post-market surveillance and UDI. 510(k) for instruments isn't the same bar; traceability and vigilance still essential.

#PointOfCare #Diagnostics #Cardiology

@ai-medicalcongress.bsky.socialSep 7, 2026, 3:59 AM

Join global experts at AIIM 2027 and explore the latest innovations in AI in Medical Imaging & Diagnostics.

📅 June 03–04, 2027
📍 Amsterdam, Netherlands

🌐 AIIM 2027 Official Website

#AIIM2027 #AIinMedicine #MedicalImaging #Diagnostics #HealthcareAI #RadiologyAI #DigitalHealth

Photo, no description
@cardiophoenix.bsky.socialSep 6, 2026, 12:41 PM

Earlier suspicion speeds care. Cardio-HART aids.

#Diagnostics #DigitalHealth #PointOfCare

@drsarahwh.bsky.socialSep 6, 2026, 12:26 PM

Spectrum bias: tests lie in ideal samples

#MedTech #ClinicalValidation #Diagnostics

@dabishnhs.bsky.socialSep 5, 2026, 11:47 AM

69,424 MAUDE reports Apr-Aug with no identified device problem, alarming; underfunded mean hospitals (and taxpayers) pay later.

#HeartFailure #Diagnostics #HealthInequality

@currentmedscience.bsky.socialSep 3, 2026, 1:00 PM

#ALOX5 is a reliable diagnostic marker in #DKD, linked to immunity and #Ferroptosis. This strengthens prospects for precision #Diagnostics and patient care. #medsky

Know more: doi.org/10.1007/s115...

#currentmedicalscience #Nephrology #Biomarkers #ClinicalResearch

@cvia-journal.orgSep 3, 2026, 12:36 PM

MCG offers non-invasive, radiation-free, and highly sensitive diagnostics for #CVD. This study reviews device classification, clinical applications, market challenges, and prospects. #medsky
#OpenAccess: doi.org/10.15212/CVI...
#CVIA #Cardiology #MedicalDevices #Diagnostics

@cardiobeast.bsky.socialSep 3, 2026, 3:00 AM

Lower referral thresholds from a new test will FLOOD echo services. If you don't plan capacity, waitlists and unnecessary scans follow. Prep now, not later.

#DigitalHealth #Echocardiography #Diagnostics